YEAR
- 2016.01.19 Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies. Matsushita M, Otsuka Y, Tsutsumida N, Tanaka C, Uchiumi A, Ozawa K, Suzuki T, Ichikawa D, Aburatani H, Okamoto S, Kawakami Y, Hattori Y.PLoS ONE. 2016;11(1):e0146371. doi: 10.1371/journal.pone.0146371
- 2016.01.12 IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis. Asano Y, Kawase T, Okabe A, Tsutsumi S, Ichikawa H, Tatebe S, Kitabayashi I, Tashiro F, Namiki H, Kondo T, Semba K, Aburatani H, Taya Y, Nakagama H, Ohki R.Sci Rep. 2016 Jan 12;6:19174. doi: 10.1038/srep19174
- 2016.01.12 Genomic characterization of primary central nervous system lymphoma. Fukumura K, Kawazu M, Kojima S, Ueno T, Sai E, Soda M, Ueda H, Yasuda T, Yamaguchi H, Lee J, Shishido-Hara Y, Sasaki A, Shirahata M, Mishima K, Ichimura K, Mukasa A, Narita Y, Saito N, Aburatani H, Nishikawa R, Nagane M, Mano H.Acta Neuropathol. 2016 06;131(6):865-75. doi: 10.1007/s00401-016-1536-2
- 2016.01.05 The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival. Ohguchi H, Hideshima T, Bhasin MK, Gorgun GT, Santo L, Cea M, Samur MK, Mimura N, Suzuki R, Tai YT, Carrasco RD, Raje N, Richardson PG, Munshi NC, Harigae H, Sanda T, Sakai J, Anderson KC.Nat Commun. 2016 Jan 05;7:10258. doi: 10.1038/ncomms10258
CLOSE